Cameco's Comeback Bid: Uranium Contract Prices and Westinghouse IPO Fuel a Two-Sided Bull Case
Published on 08/04/2026 at 06:23 | Redaktion boerse-global.de
The recent bounce in Cameco's share price tells two stories at once. On the Frankfurt exchange, the stock has clawed back 4.14 percent to close at 77.98 euros, a move that follows a bruising 8.52 percent slide over the preceding 30 days. Yet the weekly chart still shows a gain of 2.15 percent, and that mixed picture has analysts split between seeing a dead-cat bounce and the end of an overdone correction.
UBS has come down firmly on the side of the bulls. The Swiss bank upgraded Cameco from Neutral to Buy, setting a price target of 166 Canadian dollars. Its reasoning: record long-term uranium contract prices, growing utility demand for new supply agreements, and sustained government backing for nuclear power. Crucially, UBS attributed the recent share-price weakness to broad market jitters and AI-sentiment swings rather than any deterioration in the underlying business.
That diagnosis matters. If the sell-off was sentiment-driven, the recovery has room to run once nerves settle. The technical indicators support a cautious optimism. The relative strength index sits at 46.1 — comfortably neutral, neither oversold enough to signal capitulation nor overbought enough to warn of an imminent reversal. With annualized 30-day volatility hovering near 39 percent, the stock remains locked in a wide trading range rather than breaking decisively in either direction.
The Contract Price Engine
The real bull case for Cameco has little to do with daily price action and everything to do with pricing power embedded in its long-term order book. Uranium contract prices climbed to an average of 86.50 US dollars per pound in December 2025, approaching the roughly 90-dollar highs last seen in 2008. Cameco's strategy of locking in multi-year supply agreements means those elevated prices get secured across several production years.
Should investors sell immediately? Or is it worth buying Cameco?
RBC Capital's analysts, after investor meetings through June, confirmed that actual contract signings are running well above the officially reported term prices. That suggests the pricing environment for new uranium deals is even stronger than headline data indicates.
The quarterly numbers released today add texture to that picture. Cameco reported a 7 percent revenue decline to 814 million US dollars, with adjusted EBITDA falling 42 percent year-on-year to 391 million. Adjusted earnings per share came in at 0.18 Canadian dollars, well short of the 0.38 Canadian dollars analysts had penciled in. Uranium sales volumes dropped 18 percent to 7.1 million pounds, partly reflecting a 15 percent production decline to 3.9 million pounds. Yet the average realized price per pound jumped 15 percent to 93.13 US dollars, underscoring how contract pricing is outpacing spot-market fluctuations.
Westinghouse: The Strategic Catalyst
Investor attention, however, has fixed on a different milestone. Cameco announced that registration papers have been filed for the initial public offering of Westinghouse Electric, the nuclear technology subsidiary in which it holds 49 percent, with Brookfield Renewable Partners controlling the remaining 51 percent. Westinghouse's technology powers roughly 57 percent of the world's 417 operational nuclear reactors, and its pipeline holds 91 potential AP1000 reactor projects.
The subsidiary posted a net loss of 10 million US dollars for the quarter, which Cameco attributed to the expiry of project benefits from the prior year. But the strategic narrative centers on long-term demand from the global expansion of nuclear capacity — a story reinforced by the growing electricity appetite of AI data centers, which increasingly look to baseload nuclear power as a solution.
Where Skepticism Lingers
The bullish case does not erase all caution. By conventional valuation metrics, the stock is hardly cheap. Operational disruptions in Saskatchewan, including weather-related logistics problems at the Cigar Lake mine, serve as reminders that execution risks exist alongside the pricing story. Management has consistently reaffirmed its production guidance — the full-year 2026 range remains 19.5 to 21.5 million pounds of uranium, with revenue guidance narrowed to 3.32 to 3.57 billion US dollars — but the gap between neutral RSI readings and elevated volatility suggests choppy trading ahead.
Cameco at a turning point? This analysis reveals what investors need to know now.
The company's balance sheet offers some ballast: 1.1 billion US dollars in cash against roughly one billion in debt, supporting a market capitalization of approximately 32.58 billion euros.
Institutional investors appear undeterred by the earnings miss. Rathbones Group increased its stake by 5.3 percent to nearly 590,000 shares, while Vanguard and Van Eck also built positions ahead of the results. Wealth Awesome's analysts see substantial upside, setting a price target of 179.65 Canadian dollars, and the broader analyst community leans predominantly toward buy ratings.
CEO Tim Gitzel struck an optimistic tone, noting that overall market conditions for nuclear energy continue to improve. For investors weighing the recent share-price weakness, the question comes down to whether the past month represented a valuation correction or something more fundamental. With contract prices near multi-year highs, a Westinghouse IPO on the horizon, and analysts turning more bullish even during the sell-off, the evidence increasingly points to the former — though the high volatility and neutral technical readings argue for patience rather than haste.
Ad
Cameco Stock: New Analysis - 4 August
Fresh Cameco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
